Translational Medicine -- Research Starter Grants

Funding Agency:
Pharmaceutical Research and Manufacturers of America Foundation

Translational medicine is a discipline focused on bridging discoveries in experimental and computational research to their application in clinical practice. To be successful, this requires working with clinicians to first identify critical unmet clinical needs, including in areas of diagnostic medicine. Examples of research may include molecular and cellular biology, pathophysiology, systems biology, bioinformatics, modeling and simulation, and other quantitative sciences that connect basic biological concepts to unmet medical needs. Clinical observation should serve as the basis for hypothesis generation to further basic research and to efficiently advance research results to improve care and management of patients.

The goal of the PhRMA Foundation’s Translational Medicine Program is to promote the development of an integrative approach that addresses clinical needs in diagnosis, treatment and prevention using both experimental and computational methods. The Foundation believes that, towards this goal, it is critical that researchers collaborate with clinicians to identify critical unmet clinical needs. This can lead to an enhanced understanding of human biological and disease processes but requires a strong translational component that is bi-directional, i.e., starting from bedside to bench. This program will support such approaches to Translational Medicine.

Deadline: Feb. 10, 2022.

Agency Website

Areas of Interest

Translational Medicine awards will advance training and support career development of scientists engaged in research that addresses clinician-defined problems and integrates innovative technologies with advanced biological, chemical, diagnostic and pharmacological sciences and engineering methodologies in areas that include but not are limited to:

  • Genetics (Molecular, Pharmaco-, Population, Medical)
  • Genomics (Functional, Structural, Toxico-, Pharmaco-, Comparative)
  • Systems (Biology and Pharmacology)
  • Pathways and Networks
  • Integrative Biology
  • Modeling and Simulation
  • Target Identification and Validation
  • Biomarker Discovery and Validation
  • Vaccine Development
  • Molecular Epidemiology
  • Imaging
  • Disease Modeling

Eligibility Requirements

  • Applicants (U.S. and non-U.S. citizens) holding the academic rank of Assistant Professor (or Research Assistant Professor) within a tenure track (or Research track) appointment, or Instructor [1], if eligible to apply for independent research funding by their institution, are eligible to apply for these research starter grants, providing their proposed research is neither directly nor indirectly already being subsidized to any significant degree by an extramural support mechanism.
  • Applicants must be based at a U.S. university or research institution in the United States. Candidates from research institutions are eligible to apply providing the institution is involved in training and education programs.
  • Individuals receiving only intramural funding or start-up funding from their institution are eligible to apply for this award.
  • Eligible candidates will not have other substantial sources of research funding.
  • The applicant must be eligible to apply for independent external research funding by their institution.
  • If other funding becomes available during the grant, the PhRMA Foundation must be notified.
  • Applicants must be sponsored by the department or unit in which the proposed research is to be undertaken.
  • This program is not offered to augment an ongoing research effort. Nor is the grant intended to be used for any direct effort to obtain further extramural funding. Funds must be used to conduct the proposed research.
  • This program is not intended for individuals in postdoctoral training. However, those enrolled in postdoctoral training programs scheduled to conclude by the start of the funding who will hold an academic appointment by that time, may apply.
  • Funding can begin as early as July 1, 2022 or on the first day of any month thereafter, up to and including December 1, 2022.
  • If multiple applicants from the same lab are submitting proposed efforts on the same project, the efforts must be separate activities. They may not be duplicative. We will not consider multiple applications for the same or similar efforts on the same project. This pertains to submissions from both categories of our Translational Medicine program. The applications will be disqualified.



Amount Description

The program provides a research grant of $100,000 for one year.

Funding Type



Junior Faculty


Engineering and Physical Sciences
Medical - Clinical Science
Medical - Translational

External Deadline

February 10, 2022